JPMorgan raised the firm’s price target on Labcorp (LH) to $330 from $319 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q4 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp: Short-Term Headwinds but Strengthening 2026 Outlook Supports Buy Rating
- Labcorp Earnings Call Highlights Growth, Investment, Risks
- Labcorp guidance ‘should be well received,’ says Morgan Stanley
- Morning Movers: Masimo surges, Danaher slumps after $9.9B deal
- Labcorp reports Q4 adjusted EPS $4.07, consensus $3.94